programma definitivo - SocietÃ italiana di neurologia

More documents

Recommendations

Info

5 N O V E M B R E • A R E A P O S T E R SCLEROSI MULTIPLA 4 Moderatori R. BERGAMASCHI (Pavia) - A. BERTOLOTTO (Torino) 729. LOW INTER-RATER AGREEMENT IN CHRONIC CEREBROSPINAL VENOUS INSUFFICIENCY (CCSVI) O. RAYMKULOVA, A. LUCENTI, A. STECCO, L. BOLAMPERTI, L. COPPO, W. LIBONI, G. RIVADOSSI, G. ZACCALA, M. MAGGIO, F. MELIS, C. GIACCONE, A. CARRIERO, P. LOCHNER, M. LEONE (Novara) 730. OUTCOME OF ISOLATED ACUTE TRANSVERSE MYELITIS AND PREDICTIVE FACTORS FOR CONVERSION TO MULTIPLE SCLEROSIS V. MARIANI, E. AMBROSONI, M. MONTAGNA, M. MAURI, P. BANFI (Varese) 731. CHARACTERIZATION OF HUMORAL RESPONSE TO EPSTEIN-BARR NUCLEAR ANTIGEN-1 IN PATIENTS WITH MULTIPLE SCLEROSIS R. MECHELLI, F. PRATESI, D. VITTORI, C. POLICANO, C. BUSCARINU, V. RICIGLIANO, P. MIGLIORINI, G. RISTORI, M. SALVETTI (Roma, Pisa) 732. MEANING OF TH22 EXPANSION IN MULTIPLE SCLEROSIS DISEASE ACTIVITY S. DE MERCANTI, M. CLERICO, S. ROLLA, V. BARDINA, P. QUAGLINO, R. DE PALMA, F. PIAZZA, D. GNED, F. NOVELLI, L. DURELLI (Orbassano - TO, Torino, Napoli) 733. ATTITUDES TOWARDS CLINICAL TRIALS IN MS PATIENTS: LEARNING FROM CCSVI S. MAIDA, M. MESSINA, M. ROMEO, F. POSSA, G. COMI, V. MARTINELLI (Milano) 734. THE EFFICACY OF NATALIZUMAB AND FINGOLIMOD ON COGNITION IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS C.G. CHISARI, C. LEONE, S. CILIA, S. MESSINA, V. CIMINO, F. MASUZZO, S. LO FERMO, F. PATTI, M. ZAPPIA (Catania) 735. PATTERNS OF GREY MATTER DAMAGE IN PROGRESSIVE MS: A VOXEL- BASED MORPHOMETRY STUDY VERSUS MOTOR NEURON DISORDERS E. TAVAZZI, M. LAGANÀ, N. BERGSLAND, P. TORTORELLA, G. PINARDI, C. LUNETTA, G. BASELLI, M. CORBO, M. ROVARIS (Milano) 736. EMPLOYMENT STATUS AND MULTIPLE SCLEROSIS: RESULTS FROM A LITERATURE REVIEW M. LEONARDI, S. SCHIAVOLIN, A. GIOVANNETTI, V. COVELLI, A. RAGGI, L. BRAMBILLA, R. FRANGIAMORE, M. MOSCATELLI, V. TORRI, R. MANTEGAZZA, P. CONFALONIERI (Milano) 737. PREDICTORS OF QUALITY OF LIFE AND DISABILITY IN MULTIPLE SCLEROSIS: IMPACT OF MENTAL HEALTH ISSUES M. LEONARDI, A. RAGGI, A. GIOVANNETTI, V. COVELLI, S. SCHIAVOLIN, R. MANTEGAZZA, V. TORRI, L. BRAMBILLA, R. FRANGIAMORE, M. MOSCATELLI, P. CONFALONIERI (Milano) 738. PERSISTENCE OF EFFICACY IN MULTIPLE SCLEROSIS PATIENTS DURING FINGOLIMOD THERAPY AFTER SWITCH FROM NATALIZUMAB R. CERQUA, M. DANNI, S. ZAGAGLIA, R. TAFFI, V. MIRISOLA, L. PROVINCIALI (Ancona, Genova) 739. HEALTH-RELATED QUALITY OF LIFE, FATIGUE, AND UNCERTAINTY IN A POPULATION-BASED SAMPLE OF PEOPLE WITH MULTIPLE SCLEROSIS: PRELIMINARY DATA L. SPADARO, L. GITTO, G. POLIMENI, G. VENUTI, G. D’ALEO, C. RIFICI, E. SESSA, P. BRAMANTI (Messina, Roma) 190
740. IMPACT OF SHORT TIME TO FIRST CLINICAL RELAPSE ON ATTENTIVE AND EXECUTIVE FUNCTIONS IN NEWLY DIAGNOSED MULTIPLE SCLEROSIS M.Z. CONTI, S. LA GIOIA, S. BULLA, O. MANARA, M. VEDOVELLO, M. POLONI, M. ROTTOLI (Bergamo, Milano) 741. PREVALENCE OF SERUM AUTOANTIBODIES IN PATIENTS WITH CISS SUGGESTIVE OF MULTIPLE SCLEROSIS M. DI GREGORIO, M. DI FILIPPO, L. GAETANI, S. PECORARI, P. CALABRESI, P. SARCHIELLI (Perugia, Roma) 742. FREQUENT EARLY MULTIPLE SCLEROSIS RELAPSES DURING TREATMENT WITH FINGOLIMOD: OUR EXPERIENCE D. FERRARO, L. FEDERZONI, F. VITETTA, A. SIMONE, A. COSSARIZZA, P. NICHELLI, P. SOLA (Modena) 743. NEUROBORRELIOSIS IN MULTIPLE SCLEROSIS: A CASE REPORT A. ROMAGNOLO, F. VALLELONGA, L. MARINO, G. SUPERTI, S. MASERA, P. CAVALLA (Torino) 744. SWITCHING FROM NATALIZUMAB TO FINGOLIMOD M. MELIS, E. COCCO, C. SARDU, J. FRAU, L. LOREFICE, G. FENU, G. COGHE, M. MARROSU (Cagliari) 745. FINGOLIMOD USE IN CLINICAL PRACTICE F. SACCÀ, C. PANE, G. PUORRO, A. MARSILI, R. LANZILLO, S. SABATINI, V. BRESCIA MORRA (Napoli, Origgio - VA) 746. A NEW TELEMEDICINE APPROACH TO FATIGUE MANAGEMENT TRAINING IN PATIENTS WITH MULTIPLE SCLEROSIS G. LAMPONI, F. BERTÈ, D. FERRARA, R. DE LUCA, R. CALABRÒ, P. BRAMANTI (Messina) 747. ADHERENCE TO IMMUNOMODULATORY TREATMENTS IN MULTIPLE SCLEROSIS PATIENTS: OUR EXPERIENCE D. FERRARO, F. VITETTA, A. SIMONE, L. FEDERZONI, P. LEVANTI, F. PROMPICAI, P. NICHELLI, P. SOLA (Modena) 748. FATIGUE AS A RISK FACTOR FOR WORK ACCIDENTS IN A SAMPLE OF MULTIPLE SCLEROSIS PATIENTS: A PRELIMINARY SURVEY C.C. INCERTI, O. ARGENTO, G. MAGISTRALE, C. CALTAGIRONE, G. DI BATTISTA, E. FERRARO, U. NOCENTINI, V. PISANI (Roma) 749. JCV-AB SEROSTATUS IN MS PATIENTS TREATED WITH NATALIZUMAB L. MANCINELLI, D. TRAVAGLINI, M. DI IOIA, V. DI TOMMASO, E. PIETROLONGO, D. FARINA, G. DE LUCA, A. LUGARESI (Chieti) 750. BRAINSTEM AUDITORY EVOKED POTENTIALS IN PATIENTS WITH MULTIPLE SCLEROSIS: EFFECTS OF INCREASED STIMULUS REPETITION RATE F. CAMINITI, S. DE SALVO, M. DE COLA, C. RIFICI, P. BRAMANTI, S. MARINO (Messina) 751. ATYPICAL EPENDYMAL EXOPHYTIC LESION IN A MULTIPLE SCLEROSIS PATIENT: A CASE REPORT F. SANGALLI, V. BARCELLA, M. RADAELLI, L. FERRÈ, L. MOIOLA, G. COMI, V. MARTINELLI (Milano) 752. QUALITY OF LIFE IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: CORRELATION BETWEEN SEXUAL DYSFUNCTIONS, FATIGUE AND DEPRESSION D. MEDICI, L. DELL’ATTI (Ancona, Ferrara) 753. SEVERE ANEMIA IN A PATIENT WITH MULTIPLE SCLEROSIS TREATED WITH NATALIZUMAB A.M. SIMONE, D. FERRARO, F. VITETTA, L. FEDERZONI, R. MARASCA, G. BONACORSI, P. NICHELLI, P. SOLA (Modena) 5 N O V E M B R E • A R E A P O S T E R 191
Page 1:
2 5
Page 7 and 8:
Sotto l’Alto Patronato della Pres
Page 9 and 10:
CONSIGLIO DIRETTIVO SIN Presidente
Page 11 and 12:
IN TRENO Stazione Centrale - Stazio
Page 13:
Accademia Nazionale di Medicina 16
Page 16 and 17:
AUDITORIUM SALA SILVER 12.30 - 13.3
Page 18 and 19:
2 N O V E M B R E • S A L A G I A
Page 20 and 21:
2 N O V E M B R E • S A L A CORSO
Page 22 and 23:
Page 24 and 25:
2 N O V E M B R E • CORSO A.N.I.N
Page 26 and 27:
2 N O V E M B R E • S A L A SIMPO
Page 28 and 29:
2 N O V E M B R E • S A L A B L U
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
DOMENICA 3 NOVEMBRE AUDITORIUM SALA
Page 36 and 37:
3 N O V E M B R E • A U D I T O R
Page 38 and 39:
Page 40 and 41:
3 N O V E M B R E • S A L A R O S
Page 42 and 43:
3 N O V E M B R E • COMUNICAZIONI
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
3 N O V E M B R E • S A L A B I A
Page 50 and 51:
3 N O V E M B R E • S A L A RIUNI
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
3 N O V E M B R E • S A L A WORKS
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
LUNEDI 4 NOVEMBRE AUDITORIUM SALA S
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
4 N O V E M B R E • COMUNICAZIONI
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
4 N O V E M B R E • LETTURA ore 1
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
MARTEDI 5 NOVEMBRE AUDITORIUM SALA
Page 102 and 103:
5 N O V E M B R E • S A L A BREAK
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
5 N O V E M B R E • S A L A T U R
Page 116 and 117:
5 N O V E M B R E • S A L A TRIAL
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
5 N O V E M B R E • CHIUSURA DEI
Page 128 and 129:
3 N O V E M B R E • A R E A P O S
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143: 3 N O V E M B R E • A R E A P O S
Page 152 and 153: 150
Page 194 and 195: 5 N O V E M B R E • A R E A 754.
Page 200 and 201: SEGRETERIA IN SEDE CONGRESSUALE La
Page 202 and 203: ACCREDITAMENTO ECM La Commissione N
Page 204 and 205: CERTIFICATO ECM Fin quando non era
Page 207 and 208: Si ringraziano, per l’indispensab
Page 209 and 210: SI RINGRAZIANO PER LA PARTECIPAZION
Page 212: SEGRETERIA ORGANIZZATIVA SIN Studio
show all

programma definitivo - SocietÃ italiana di neurologia

Create successful ePaper yourself

Delete template?

Save as template?